Feb 12, 2026 04:32PM
Feb 9, 2026 09:56AM
Feb 9, 2026 09:53AM
Dec 31, 2025 06:19AM
Dec 16, 2025 03:13AM
Dec 15, 2025 05:00PM
Dec 15, 2025 05:00PM XOMA to acquire Generation Bio for $4.29 per share plus contingent payments
Dec 15, 2025 05:00PM
Dec 15, 2025 05:00PM
Dec 5, 2025 09:00AM
Dec 5, 2025 09:00AM
Dec 5, 2025 07:45AM
Dec 5, 2025 07:45AM
Dec 3, 2025 04:32PM Irish court approves XOMA Royalty's acquisition of Mural Oncology
Dec 3, 2025 04:30PM
Nov 26, 2025 09:00AM
Nov 26, 2025 09:00AM
Nov 21, 2025 07:45AM
Nov 21, 2025 07:45AM
Nov 12, 2025 07:30AM
Oct 24, 2025 04:26PM Mural Oncology shareholders approve XOMA Royalty acquisition
Oct 24, 2025 04:25PM
Oct 17, 2025 11:47AM
Oct 17, 2025 11:45AM
Oct 2, 2025 04:43PM
Oct 2, 2025 04:43PM
Sep 17, 2025 09:00AM
Sep 9, 2025 08:41AM XOMA, Ltd. (XOMA) PT Raised to $50 at Benchmark
Aug 21, 2025 06:35AM
Aug 20, 2025 08:30AM
Aug 20, 2025 08:30AM
Aug 14, 2025 06:21AM
Aug 13, 2025 07:30AM
Aug 11, 2025 09:00AM
Aug 4, 2025 07:30AM XOMA Royalty to acquire LAVA Therapeutics for up to $1.24 per share
Aug 4, 2025 07:30AM
Aug 4, 2025 07:00AM
Aug 4, 2025 07:00AM
Jul 14, 2025 08:02AM
Jul 14, 2025 08:00AM
Jun 27, 2025 07:30AM
Jun 27, 2025 07:30AM Turnstone Biologics Corp. Enters into Agreement to be Acquired by XOMA Royalty Corporation for $0.34 in Cash Per Share Plus a Contingent Value Right
May 13, 2025 07:30AM
Apr 14, 2025 07:30AM
Apr 14, 2025 07:30AM
Mar 17, 2025 04:30PM
Dec 3, 2024 06:48AM
Dec 2, 2024 07:31AM
Dec 2, 2024 07:30AM XOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its Portfolio
Nov 7, 2024 07:30AM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All